Longboard pharmaceuticals to participate in three upcoming investor conferences

La jolla, calif.--(business wire)---- $lbph #epilepsy--longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that members of its senior management team will participate in three upcoming investor conferences in september. conference details: event: citi 18th annual biopharma conference details: hosting investor meetings thursday, september 7, 2023, in boston, ma event: h.c. wainwrig.
LBPH Ratings Summary
LBPH Quant Ranking